Last update 01 Nov 2024

Antimetallothionein antibody (Biohaven Pharmaceuticals)

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
UC1MT (Biohaven Pharmaceuticals)
Target
Metallothionein
Mechanism
Metallothionein inhibitors, Immunomodulators
Therapeutic Areas
Immune System DiseasesOther Diseases
Active Indication
Autoimmune DiseasesInflammation
Inactive Indication-
Originator Organization
University of ConnecticutUniversity of Connecticut
Active Organization
Ghent UniversityGhent UniversityUniversity of ConnecticutUniversity of ConnecticutJoslin Diabetes Center, Inc.Joslin Diabetes Center, Inc.
Inactive Organization
Biohaven Pharmaceuticals, Inc.
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Antimetallothionein antibody (Biohaven Pharmaceuticals)
Login to view more data
100 Translational Medicine associated with Antimetallothionein antibody (Biohaven Pharmaceuticals)
Login to view more data
100 Patents (Medical) associated with Antimetallothionein antibody (Biohaven Pharmaceuticals)
Login to view more data
100 Deals associated with Antimetallothionein antibody (Biohaven Pharmaceuticals)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoimmune DiseasesPreclinical
US
Biohaven Pharmaceuticals, Inc.
-
Autoimmune DiseasesPreclinical
US
University of ConnecticutUniversity of Connecticut
-
Autoimmune DiseasesPreclinical
US
Joslin Diabetes Center, Inc.Joslin Diabetes Center, Inc.
-
Autoimmune DiseasesPreclinical
US
Ghent UniversityGhent University
-
InflammationPreclinical
US
Joslin Diabetes Center, Inc.Joslin Diabetes Center, Inc.
-
InflammationPreclinical
US
Biohaven Pharmaceuticals, Inc.
-
InflammationPreclinical
US
Ghent UniversityGhent University
-
InflammationPreclinical
US
University of ConnecticutUniversity of Connecticut
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free